Table 2

Threshold analysis results in three genotypes

Genotype	Comparator	DAA drugs	Threshold price (US$)	Price reduction (%)
Genotype 2	SOF/VEL	Sofosbuvir	2723	8
	SOF/VEL	Daclatasvir	391	41
	To be cost-saving	Sofosbuvir	2127	28
		Daclatasvir	247	63
		Sofosbuvir/velpatasvir	2622	25
Genotype 3	SOF-DCV	Sofosbuvir	2055	31
	SOF-DCV	Sofosbuvir/velpatasvir	3141	10
	To be cost-saving	Sofosbuvir	1642	45
	To be cost-saving	Sofosbuvir/velpatasvir	2613	25
Genotype 6	SOF-RBV	Sofosbuvir	2056	31
		Daclatasvir	457	31
		Sofosbuvir/velpatasvir	2798	20

DAA, direct-acting antiviral; SOF-DCV, sofosbuvir plus daclatasvir; SOF-RBV, sofosbuvir plus ribavirin; SOF/VEL, sofosbuvir/velpatasvir.